KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Net Cash Flow (2016 - 2025)

Eli Lilly (LLY) has disclosed Net Cash Flow for 17 consecutive years, with -$2.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 850.27% year-over-year to -$2.5 billion, compared with a TTM value of $3.6 billion through Dec 2025, up 386.33%, and an annual FY2025 reading of $3.6 billion, up 386.33% over the prior year.
  • Net Cash Flow was -$2.5 billion for Q4 2025 at Eli Lilly, down from $6.4 billion in the prior quarter.
  • Across five years, Net Cash Flow topped out at $6.4 billion in Q3 2025 and bottomed at -$2.5 billion in Q4 2025.
  • Average Net Cash Flow over 5 years is $187.0 million, with a median of $2.6 million recorded in 2022.
  • The sharpest move saw Net Cash Flow plummeted 16689.47% in 2023, then soared 7933.5% in 2025.
  • Year by year, Net Cash Flow stood at $251.0 million in 2021, then crashed by 268.21% to -$422.2 million in 2022, then surged by 173.07% to $308.5 million in 2023, then rose by 6.13% to $327.4 million in 2024, then tumbled by 850.27% to -$2.5 billion in 2025.
  • Business Quant data shows Net Cash Flow for LLY at -$2.5 billion in Q4 2025, $6.4 billion in Q3 2025, and $7.1 million in Q2 2025.